EMPULSE: The ‘missing link’ for empagliflozin in heart failure | Adriaan Voors

Adriaan Voors discusses the EMPULSE trial of empagliflozin given just after stabilization of de novo or decompensated chronic heart failure (5:21).
View more on Medicine Matters diabetes: diabetes.medic... and remember to Like this video and Subscribe to our channel.